Searched for
PULMONARY ARTERIAL HYPERTENSION
Prateek Yadav death mystery deepens as postmortem reveals six unexplained injuriesPrateek Yadav passed away yesterday. Six antemortem injuries were found on his body, with three dating back five to seven days and three ab...- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 28%In these times of geopolitical stress, how will things pan out for the Indian market? Will it be a standalone underperformer? Or is it just...
- Scuba diving isn’t risk-free: Eye-opening lessons from tragedies and how to protect yourselfScuba diving, while captivating, carries underestimated risks, demanding personal responsibility and specialized medical awareness. Pre-exi...
- Natco Pharma launches generic drug with 180-day exclusivity in USNatco Pharma has launched Bosentan tablets, a generic version of Tracleer, in the US for treating pulmonary arterial hypertension in young ...
- NPS partial withdrawal new rules: All you need to knowNPS withdrawal rules: PFRDA has issued a master circular dated January 12, 2024 to facilitate partial withdrawals and guarantee compliance ...
- Five people succumb to Covid in last 24 hours, 511 cases of JN.1 series variant reported till January 2602 new cases have been registered in the last 24 hours, and the total number of cases stood at cases are 4,50,15,136, the Ministry of Heal...
- This injection can breathe life back into your heartA new biomaterial, if injected, can repair damaged cardiac tissue.
- Cipla to invest 15 million euros in Germany’s Ethris to expand respiratory portfolioThe investment will facilitate a long-term strategic partnership between Cipla and Ethris for development of messenger RNA (mRNA)-based the...
- World Heart Day 2022: Cardiovascular diseases killing Indians the most; know about pulmonary embolism & rheumatic conditionWorld Heart Day: India accounts for approximately 60 per cent of the world's heart disease burden.
- Alembic gets USFDA nod for generic hypertension treatment drugAlembic's product is the generic equivalent to the reference listed drug product (RLD) Uptravi.
- Hypertensive patients most likely to develop post-Covid complications: StudyThe American study showed that hypertension was associated with 10 complications, including acute respiratory distress syndrome, improper b...
- Alembic Global Holding SA gets USFDA nod for pulmonary arterial hypertension treatment injectionDrug firm Alembic Pharmaceuticals on Friday said its arm, Alembic Global Holding SA, has received approval from the US health regulator for...
- Alembic Pharma arm gets tentative USFDA nod for drug to treat pulmonary arterial hypertensionAlembic Global Holdings SA has received tentative approval from the US Food and Drug Administration for its abbreviated new drug applicatio...
- World COPD Day: Quit smoking, wear a mask; incessant coughing, swollen feet are warning signsThe muscles used in breathing might require 10 times more calories than a healthy person.
- Cipla gets USFDA nod for pulmonary arterial hypertension drugCipla said the US sales of Letairis tablets USP stood at USD 943 million in 2018.
- Aurobindo Pharma gets USFDA nod for generic of Pfizer's RevatioAurobindo Pharma received approval from the USFDA to manufacture and market generic version of Pfizer's Revatio tablets used in the treatme...
- Aurobindo Pharma shares gain 6.5 per cent on USFDA nodThe scrip jumped 6.19 per cent to settle the day at Rs 1,324.95 on the BSE. In intra-day, it gained 6.59 per cent to Rs 1,330, its 52-week ...
- Aurobindo Pharma gets USFDA nod for Sildenafil injectionUSFDA-approved Sildenafil injection, treats pulmonary arterial hypertension and is a generic version of Pfizer's Revatio injection.
- GlaxoSmithKline Pharma Q4 net profit inches up 1.29% at Rs 138.51 croreThe company had posted a net profit of Rs 136.74 crore for the corresponding period previous fiscal, the company said in a statement.
- Brokers' call on Tata Steel, Bharti Airtel and GSK PharmaMacquarie has downgraded the ratings of Tata Steel to ‘Underperform’ with a target price of Rs 306. Tata Steel, on a P/B adjusted for goodw...
Load More
